RecruitingNCT06928727

Ocular Characteristics in Patients With Craniosynostosis


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

65 participants

Start Date

Apr 4, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Craniosynostosis are cranial deformations due to the premature closure of one or more cranial sutures. These deformations affect approximately one in 2.500 births. In most cases, craniosynostoses are isolated with unknown (non syndrome). On the other hand, 20% of these deformations are associated with other concentration (syndrome). Craniosynostosis has morphological (associated dysmorphism) and functional (growth conflict between the skull and the brain) repercussions. Ophthalmological disorders are frequent: refractive disorders, oculomotor disorders, optic nerve damage, sensory damage. This retrospective study aims to describe the ocular clinical characteristics associated with craniosynostosis in patients followed at the Amiens University Hospital.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study examines eye characteristics and vision problems in patients who have craniosynostosis, a condition where the bones of the skull fuse too early in development. Researchers want to better understand how this condition affects the eyes. **You may be eligible if...** - You have been diagnosed with craniosynostosis (early fusing of skull bones) **You may NOT be eligible if...** - Your head shape issue is due to positional causes (posterior plagiocephaly — flat head from lying in one position), not true craniosynostosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHRU Amiens

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06928727


Related Trials